How Can Equitable CAR T-Cell Therapy Access Be Increased?
https://vimeo.com/926992122 How can CAR T-cell therapy access issues be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic explains some common access issues that can arise for patient CAR T care and some…
How Are Cultural and Language Barriers to CAR T Therapy Being Addressed?
https://vimeo.com/926992189 How are CAR T therapy barriers of cultural and language nature being addressed? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses research study results on access barriers and ways to create…
Roadblocks for Black and Latinx Patients From CAR T Trial Access
https://vimeo.com/926992230 What are CAR T-cell therapy roadblocks for Black and Latinx trial access? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses barriers that have been documented in clinical research and solutions and…
Reducing CAR T-Cell Therapy Barriers for Relapsed/Refractory Myeloma
https://vimeo.com/926992265 How can CAR T-cell therapy barriers for relapsed/refractory myeloma be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic shares his perspective about barriers to CAR T and advice for patients to…
How Can CAR T-Cell Therapy Be Explained to Patients and Families?
https://vimeo.com/926992331 How can patients and families be educated about CAR T-cell therapy? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses the approach he takes to explaining the treatment to those new to…
How Is Advanced Renal Cell Carcinoma Patient Care Managed?
https://vimeo.com/925121970 Dr. Moshe Ornstein from Cleveland Clinic delves into the management of advanced renal cell carcinoma, where the cancer has spread beyond the kidney. He highlights that while the majority of…
Expert Insights into Kidney Cancer Risk Factors and Genetic Testing
https://vimeo.com/925122438 What is known about kidney cancer risk factors and genetic testing? Expert Dr. Moshe Ornstein from Cleveland Clinic explains known risk factors for kidney cancer and situations when he recommends genetic…
Diagnosed with Renal Cell Carcinoma? Start Here
What’s important for newly diagnosed renal cell carcinoma patients to know? Expert Dr. Moshe Ornstein from Cleveland Clinic discusses his approach to communicating with newly diagnosed patients and key points that he…
Renal Cell Carcinoma Clinical Trials | A Deep Dive into the Latest Advancements
https://vimeo.com/925122237 What’s the latest in renal cell carcinoma clinical trial news? Expert Dr. Moshe Ornstein from Cleveland Clinic discusses updates on antibody drug conjugates, targeted therapy, checkpoint inhibitors, bispecific antibodies, vascular endothelial…
Exploring Renal Cell Carcinoma Research: Expert Insights on Immunotherapy and Targeted Therapy
https://vimeo.com/925122081 What’s important in renal cell carcinoma research news? Expert Dr. Moshe Ornstein from Cleveland Clinic shares an overview of research updates on immunotherapy, targeted therapy, and combination therapies. Download Resource Guide…
Advancing Equity | Research Initiatives in AML Disparities Among Black and Latinx Populations
What AML research efforts are underway to advance equity among Black and Latinx and populations? Expert Dr. Sara Taveras Alam from UTHealth Houston discusses initiatives that are working to improve AML care…
Do AML Patients Receive Allo or Auto Stem Cell Transplant?
https://vimeo.com/925582477 What type of stem cell transplant do AML patients receive? Expert Dr. Sara Taveras Alam from UTHealth Houston explains stem cell transplant for AML care and advice to help patients locate…